TEVA PHARMACEUTICAL WORKS PLC

Company Type: Factory

Company Introduction:

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company and "TEVA PHARMACEUTICAL WORKS PLC" refers to one of its manufacturing operations located in India. Teva Pharmaceutical has a significant presence in India, primarily engaged in the manufacturing of a wide range of generic medicines, active pharmaceutical ingredients (APIs), and some specialty products.

The Indian facilities are crucial to Teva's global supply chain, producing high-quality, affordable medicines for both the local market and for export to various international markets. These manufacturing plants adhere to stringent global regulatory standards, including those set by the US FDA, European Medicines Agency (EMA), and other health authorities worldwide.

Teva's operations in India are characterized by robust research and development capabilities, advanced production technologies, and a strong focus on quality control. The company leverages India's skilled workforce and established pharmaceutical ecosystem to contribute to its mission of providing access to essential medicines globally. Therefore, "TEVA PHARMACEUTICAL WORKS PLC" functions as a manufacturing unit within the larger Teva Pharmaceutical network.

TEVA PHARMACEUTICAL WORKS PLC, as part of Teva Pharmaceutical Industries Ltd.'s global operations, manufactures and sells a wide range of pharmaceutical products in India. The company primarily focuses on generic medicines, active pharmaceutical ingredients (APIs), and certain specialty products.

The product portfolio in India covers various therapeutic areas, including but not limited to:

Cardiovascular diseases

Central nervous system disorders

Respiratory conditions

Oncology

Pain and inflammation

Infectious diseases

Gastrointestinal disorders

Metabolic disorders, including diabetes

Women's health

Dermatology

Teva is one of the world's largest producers of generic medicines, manufacturing and distributing affordable versions of branded drugs across nearly all major therapeutic categories. While specific product names are numerous and can vary, the core business in India revolves around providing high-quality, accessible generic formulations and supplying APIs globally.